Showing results (21-30 of 757) with videos related to
Sort By:
Pageof 76
Gerontology|October 27, 2010
Old donors for kidney transplantation: how old?Paolo Cravedi, Piero Ruggenenti, Giuseppe RemuzziExpert Opinion on Pharmacotherapy|October 28, 2010
Which antihypertensive drugs are the most nephroprotective and why?Paolo Cravedi, Piero Ruggenenti, Giuseppe RemuzziNephron|April 21, 2016
Progression, Remission and Regression of Chronic Renal DiseasesMonica Cortinovis, Piero Ruggenenti, Giuseppe RemuzziNature Reviews. Nephrology|May 5, 2010
The RAAS in the pathogenesis and treatment of diabetic nephropathyPiero Ruggenenti, Paolo Cravedi, Giuseppe RemuzziCurrent Opinion in Pharmacology|May 9, 2017
ACE and SGLT2 inhibitors: the future for non-diabetic and diabetic proteinuric renal diseaseNorberto Perico, Piero Ruggenenti, Giuseppe RemuzziJournal of the American Society of Nephrology : JASN|June 7, 2005
Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: the data of the meta-analysesCarlos Chiurchiu, Giuseppe Remuzzi, Piero RuggenentiCurrent Hypertension Reports|January 8, 2008
Intensified inhibition of renin-angiotensin system: a way to improve renal protection?Paolo Cravedi, Piero Ruggenenti, Giuseppe RemuzziJournal of the American Society of Nephrology : JASN|December 19, 2008
Liver-kidney transplantation to cure atypical hemolytic uremic syndromeJeffrey M Saland, Piero Ruggenenti, Giuseppe Remuzzi, et al.Journal of the American Society of Nephrology : JASN|December 6, 2002
Halting the progression of chronic nephropathyRuth C Campbell, Piero Ruggenenti, Giuseppe RemuzziCurrent Diabetes Reports|November 13, 2003
Proteinuria in diabetic nephropathy: treatment and evolutionRuth C Campbell, Piero Ruggenenti, Giuseppe RemuzziPageof 76